NCT05559333

Brief Summary

The aim of this study is to compare the clinical performances of high-viscosity glass ionomer (GI), glass carbomer (GC), zirconia-reinforced GI (ZIR), and bulk-fill (BF) composite resin restorations.For this purpose, two calibrated operators placed 128 restorations in 30 patients with a mean age of 21 years. The restorations will be evaluated by one examiner at baseline and at 6, 12, 18,24, and 48 months using the modified US Public Health Service criteria. The data will statistically analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2018

Completed
4.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 24, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
Last Updated

September 29, 2022

Status Verified

September 1, 2022

Enrollment Period

10 months

First QC Date

September 25, 2022

Last Update Submit

September 25, 2022

Conditions

Keywords

glass ionomer cementsbioactive materials

Outcome Measures

Primary Outcomes (1)

  • Retention Alpha for at least 90% of the restorations

    The primary factor for determining the clinical performance of a restorative material is the retention rate. It represents the survival rates of the restorations after a period of time. According to ADA guidelines, a restorative material should show at leat 90% alpha retention rate after 18 months to be considered as clinically acceptable. The retention is assesed as alpha (retentive restoratation) or charlie (failed restoration). Clinical evaluation is performed to examine if the restoration is in place or has fallen.

    24 months

Secondary Outcomes (1)

  • marginal adaptation score alpha

    24 months

Study Arms (4)

zirconomer

ACTIVE COMPARATOR

zirconia reinforced glass ionomer cement

Procedure: class I restoration placement

Equia Fil

ACTIVE COMPARATOR

High viscosity glass ionomer cement

Procedure: class I restoration placement

glass carbomer

ACTIVE COMPARATOR

glass ionomer cement containing nano sized- carbonized particles.

Procedure: class I restoration placement

Tetric-evo ceram bulk fill

ACTIVE COMPARATOR

Bulk fill composite resin

Procedure: class I restoration placement

Interventions

zirconomer, glass carbomer, glass ionomer and composite resin class I restorations were placed.

Equia FilTetric-evo ceram bulk fillglass carbomerzirconomer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients presenting 1) at least four single-surface occlusal caries on their posterior molar teeth (first and/or second molars); 2) teeth to be restored had to be vital and without pulpal or periodontal disease, pain, and preoperative sensitivity; 3) teeth should be in occlusion; and 4) must agree to come to follow-up appointments.

You may not qualify if:

  • patients with 1) poor oral hygiene, serious health problems, and/or heavy bruxism; 2) partly erupted teeth; 3) absence of adjacent and antagonist teeth; 4) teeth with interproximal caries; and 5) inability to attend recalls.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Altındağ, 06230, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: randomized-split mouth clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

September 25, 2022

First Posted

September 29, 2022

Study Start

April 12, 2017

Primary Completion

February 15, 2018

Study Completion

March 24, 2022

Last Updated

September 29, 2022

Record last verified: 2022-09

Locations